Michaela A. Ihle

2.6k total citations
23 papers, 663 citations indexed

About

Michaela A. Ihle is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Michaela A. Ihle has authored 23 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Michaela A. Ihle's work include Sarcoma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Genomics and Diagnostics (6 papers). Michaela A. Ihle is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Genomics and Diagnostics (6 papers). Michaela A. Ihle collaborates with scholars based in Germany, United States and Sweden. Michaela A. Ihle's co-authors include Sabine Merkelbach‐Bruse, Reinhard Büttner, Hans‐Ulrich Schildhaus, Jana Fassunke, Katharina König, Carina Heydt, Max Schlaak, Nicole Kreuzberg, Inga Grünewald and L. Tietze and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Michaela A. Ihle

22 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaela A. Ihle Germany 13 310 283 259 177 99 23 663
Tsui‐Lien Mao Taiwan 14 500 1.6× 161 0.6× 321 1.2× 188 1.1× 146 1.5× 24 1.0k
Sung‐Im Do South Korea 16 399 1.3× 175 0.6× 340 1.3× 258 1.5× 127 1.3× 84 913
Takuji Mori Japan 16 513 1.7× 181 0.6× 515 2.0× 254 1.4× 48 0.5× 31 1.0k
Nobuteru Kikkawa Japan 14 369 1.2× 164 0.6× 404 1.6× 83 0.5× 165 1.7× 71 811
Elisa Gruppioni Italy 15 274 0.9× 155 0.5× 216 0.8× 136 0.8× 75 0.8× 56 703
Nobue Kumaki Japan 14 135 0.4× 144 0.5× 300 1.2× 201 1.1× 85 0.9× 47 600
Princy Francis United States 12 352 1.1× 228 0.8× 180 0.7× 236 1.3× 76 0.8× 16 627
Linni Fan China 16 319 1.0× 93 0.3× 151 0.6× 186 1.1× 128 1.3× 50 649
F. De Vita Italy 11 198 0.6× 196 0.7× 405 1.6× 220 1.2× 67 0.7× 37 691

Countries citing papers authored by Michaela A. Ihle

Since Specialization
Citations

This map shows the geographic impact of Michaela A. Ihle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela A. Ihle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela A. Ihle more than expected).

Fields of papers citing papers by Michaela A. Ihle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela A. Ihle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela A. Ihle. The network helps show where Michaela A. Ihle may publish in the future.

Co-authorship network of co-authors of Michaela A. Ihle

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela A. Ihle. A scholar is included among the top collaborators of Michaela A. Ihle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela A. Ihle. Michaela A. Ihle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ihle, Michaela A., Pallab Maity, Mathilda T.M. Mommersteeg, et al.. (2025). BMP signaling promotes zebrafish heart regeneration via alleviation of replication stress. Nature Communications. 16(1). 1708–1708. 5 indexed citations
2.
Ihle, Michaela A., Carina Heydt, Anne M. Schultheis, et al.. (2024). Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters. Scientific Reports. 14(1). 13069–13069. 2 indexed citations
3.
Heydt, Carina, Michaela A. Ihle, & Sabine Merkelbach‐Bruse. (2023). Overview of Molecular Detection Technologies for MET in Lung Cancer. Cancers. 15(11). 2932–2932. 7 indexed citations
4.
Wagener‐Ryczek, Svenja, Carina Heydt, Sebastian Michels, et al.. (2020). Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors. BMC Cancer. 20(1). 408–408. 20 indexed citations
5.
Perkhofer, Lukas, Johann Gout, Frank Arnold, et al.. (2020). Making use of synergistic targeting to treat DNA damage repair deficient pancreatic cancer. Zeitschrift für Gastroenterologie. 2 indexed citations
6.
Ihle, Michaela A., Sebastian Huss, Wolfgang Hartmann, et al.. (2018). Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment. PLoS ONE. 13(2). e0193048–e0193048. 18 indexed citations
7.
Alidousty, Christina, Luciano G. Martelotto, Carina Heydt, et al.. (2018). Genetic instability and recurrent MYC amplification in ALK‐translocated NSCLC: a central role of TP53 mutations. The Journal of Pathology. 246(1). 67–76. 42 indexed citations
9.
Fassunke, Jana, Michaela A. Ihle, Dido Lenze, et al.. (2017). EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(4). 509–520. 23 indexed citations
10.
Helbig, Doris, Alexander Quaas, Cornelia Mauch, et al.. (2017). Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomas. Oncotarget. 8(65). 109457–109467. 31 indexed citations
11.
Koleczko, Sophia, Matthias Scheffler, Michaela A. Ihle, et al.. (2016). A comprehensive analysis of potentially targetable genetic aberrations and clinical findings in 821 patients with squamous-cell NSCLC – a comparison of NGM and TCGA LUSC data. Annals of Oncology. 27. vi420–vi420. 1 indexed citations
12.
Castiglione, Roberta, Michaela A. Ihle, Carina Heydt, et al.. (2016). The impact of sequencing on diagnosis and treatment of malignant melanoma. Expert Review of Molecular Diagnostics. 16(4). 423–433.
13.
Helbig, Doris, Michaela A. Ihle, Iliana Tantcheva‐Poór, et al.. (2016). Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas. Oncotarget. 7(16). 21763–21774. 73 indexed citations
14.
Ihle, Michaela A., Marcel Trautmann, Sebastian Huss, et al.. (2015). miRNA‐221 and miRNA‐222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours. Molecular Oncology. 9(7). 1421–1433. 71 indexed citations
15.
Heydt, Carina, Jana Fassunke, Helen Künstlinger, et al.. (2015). Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy. BMC Cancer. 15(1). 291–291. 6 indexed citations
16.
Schmitz, Katja, Hartmut Koeppen, Elke Binot, et al.. (2015). MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas. PLoS ONE. 10(4). e0120079–e0120079. 15 indexed citations
17.
Künstlinger, Helen, Jana Fassunke, Hans‐Ulrich Schildhaus, et al.. (2015). FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro. Oncotarget. 6(24). 20215–20230. 23 indexed citations
18.
Ihle, Michaela A., Sabine Merkelbach‐Bruse, Wolfgang Hartmann, et al.. (2015). HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat. The Journal of Pathology Clinical Research. 2(2). 59–71. 11 indexed citations
20.
Heydt, Carina, Jana Fassunke, Helen Künstlinger, et al.. (2014). Comparison of Pre-Analytical FFPE Sample Preparation Methods and Their Impact on Massively Parallel Sequencing in Routine Diagnostics. PLoS ONE. 9(8). e104566–e104566. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026